Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Philip, Arlen"'
Autor:
Massimo Fantini, Kwong Y Tsang, Christina Annunziata, Philip Arlen, Anjum Zaki, Sharon Mavroukakis, Charalampos S Floudas, Jamie Hur, Azam Ghafoor, Ann McCoy, Erica Redmond, Christine Feierabend
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/db95603f19224ab78a0c8f0e533912fb
Autor:
Andrea Duminuco, Kwong Tsang, Nunziatina Laura Parrinello, Sara Marino, Loredana Villari, Massimo Fantini, Giuseppe Palumbo, Francesco DI Raimondo, Philip Arlen, Alessandra Romano
Publikováno v:
HemaSphere, Vol 7, p e81710fa (2023)
Externí odkaz:
https://doaj.org/article/1b4d3a4c52124bf08641b12e5ca9d5ac
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/e669abb2174344a88708e736457f68ae
Autor:
Kwong Tsang, Massimo Fantini, Philip Arlen, Alessandra Romano, Nunziatina Parrinello, Sara Marino, Enrico La Spina, Francesco Di Raimondo
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/9ff226f633db41cbb0d58e8ea0d795b6
Autor:
Massimo Fantini, Anjum Zaki, Sharon Mavroukakis, Christina Annunziata, Philip Arlen, Kwong Tsang
Publikováno v:
Regular and Young Investigator Award Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0a628b9d1a52028911b591ad6488c07d
https://doi.org/10.1136/jitc-2022-sitc2022.0055
https://doi.org/10.1136/jitc-2022-sitc2022.0055
Autor:
Melissa Geller, Manish Patel, Hing Wong, Peter Rhode, Philip Arlen, Pallavi Chaturvedi, Jack Egan, Giles Leclerc, Martin Felices, Shannon Lunn, Bethany Hanke, Deepa Kolseri, Rose Wangen, Jeffrey Miller
Publikováno v:
Regular and Young Investigator Award Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ac87bba4ca9cc6a505b7615702130518
https://doi.org/10.1136/jitc-2022-sitc2022.0724
https://doi.org/10.1136/jitc-2022-sitc2022.0724
Autor:
Princess Mark-Adjeli, Christina Annunziata, Christopher Cole, Maria Pia Morelli, Ann McCoy, Massimo Fantini, Sharon Mavroukakis, Anjum Zaki, Kwong Tsang, Philip Arlen
Publikováno v:
Regular and Young Investigator Award Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::057f4f12f4cc820dd5562f89bf156c75
https://doi.org/10.1136/jitc-2022-sitc2022.0637
https://doi.org/10.1136/jitc-2022-sitc2022.0637
Autor:
Brandon M, Huffman, Atrayee, Basu Mallick, Nora K, Horick, Andrea, Wang-Gillam, Peter Joel, Hosein, Michael A, Morse, Muhammad Shaalan, Beg, Janet E, Murphy, Sharon, Mavroukakis, Anjum, Zaki, Benjamin L, Schlechter, Hanna, Sanoff, Christopher, Manz, Brian M, Wolpin, Philip, Arlen, Jill, Lacy, James M, Cleary
Publikováno v:
JAMA Network Open. 6:e2249720
ImportanceTreatment options are limited for patients with advanced pancreatic ductal adenocarcinoma (PDAC) beyond first-line 5-fluorouracil, leucovorin, irinotecan, and oxaliplatin (FOLFIRINOX), with such individuals commonly being treated with gemci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11e3a21732ce98e608c1b59db5d68d0c
https://doi.org/10.1001/jamanetworkopen.2022.49720
https://doi.org/10.1001/jamanetworkopen.2022.49720
Publikováno v:
Journal of Cancer, Vol 1, Iss 1, Pp 209-222 (2010)
Monoclonal antibodies developed against immunogenic proteins (Tumor Specific Antigens/TSA's) that are expressed in human cancers, display a unique behavioral pattern. They appear to serve in a dual role. This includes the early recognition of these i
Externí odkaz:
https://doaj.org/article/cbee192985da4d189e5d29cfce06a210
Autor:
James L. Gulley, Michael C. Cox, Elizabeth Jones, Suoping Zhai, Allyson Parr, Serge Cremers, William D. Figg, Yinong Liu, Clara C. Chen, William L. Dahut, Xiaowei Yang, Seth M. Steinberg, David J. Liewehr, Philip Arlen
Publikováno v:
Journal of Urology. 173:790-796
Alendronate (AL), a potent oral bisphosphonate, blocks the secretion of matrix metalloproteinase-2 and the establishment of bone metastases in animal models. Ketoconazole (KT) has demonstrated activity in androgen independent prostate cancer (AIPC).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e74c5198622a1be9ef88d90828283861
https://doi.org/10.1097/01.ju.0000147013.09157.8e
https://doi.org/10.1097/01.ju.0000147013.09157.8e